FOAMed

JC: Thromboprophylaxis for the non ICU hospitalised COVID-19 patient. St Emlyn’s

An August 2021 appraisal of therapeutic-dose heparin in hospitalised COVID-19 patients without ICU-level organ support. It examines the multiplatform trial’s benefits, bleeding-risk exclusions and composite outcome, and explains why these findings differ from those in critically ill patients.

JC: Thromboprophylaxis for the non ICU hospitalised COVID-19 patient. St Emlyn’s Read More

REGN monoclonal antibodies work in selected hospitalised COVID-19 patients. St Emlyn’s

A June 2021 review of early RECOVERY results for casirivimab and imdevimab in hospitalised COVID-19 patients. It explains the reported mortality benefit in patients without detectable antibodies, why that finding did not extend to the whole trial population, and the preliminary evidence available then.

REGN monoclonal antibodies work in selected hospitalised COVID-19 patients. St Emlyn’s Read More

Scroll to Top